![](/img/cover-not-exists.png)
Phase III Trial of Casopitant, a Novel Neurokinin-1 Receptor Antagonist, for the Prevention of Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
Herrstedt, J., Apornwirat, W., Shaharyar, A., Aziz, Z., Roila, F., Van Belle, S., Russo, M. W., Levin, J., Ranganathan, S., Guckert, M., Grunberg, S. M.Volume:
27
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2009.21.8511
Date:
November, 2009
File:
PDF, 142 KB
english, 2009